1. Allergan offloads two drugs to secure approval for merger with AbbVie — How the China coronavirus could threaten pharma's ingredient sourcing — AstraZeneca sees good results in gastric cancer and stroke studies — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Another change in Execs

Discussion in 'AIT Laboratories' started by Anonymous, Jun 27, 2013 at 9:35 AM.

  1. Anonymous

    Anonymous Guest

    Another change in execs is upon us. ME is out as CEO/President again. Now, a venture capitalist who sat on the board of directors will be CEO/President in a month or so.

    Ch-ch-changes...
     
  2. Anonymous

    Anonymous Guest

    LOL. Dr. Evans kicked Ron out because he didn't agree in the "direction" Ron was leading (e.g., a profitable and sane one). Dr. Evans comes in, screws it all up, and now the board kicks him out.

    Perfect.
     
  3. Anonymous

    Anonymous Guest

    I also heard they're changing the name now to BMO Harris Laboratories.
     
  4. Anonymous

    Anonymous Guest

    So, what is Stewie doing?
     
  5. Anonymous

    Anonymous Guest

    Who the heck is Stewie?
     
  6. Anonymous

    Anonymous Guest

    Who cares! The common denominator in this fiasco is ME